venture capital and the finance of innovation [course number]
DESCRIPTION
Venture Capital and the Finance of Innovation [Course number]. Chapter 16 Participating Convertible Preferred Stock. Professor [Name ] [School Name]. Binary Options. Binary Option Pricing formulas. Plain Binary Option. Random-Expiration Binary Option. Example 1. - PowerPoint PPT PresentationTRANSCRIPT
Venture Capital and the Finance of Innovation[Course number]
Professor [Name ][School Name]
Chapter 16Participating Convertible Preferred Stock
Binary Options
$W
Bin
ary
Cal
l at
Exp
irat
ion
X
K
Binary Option Pricing formulas
2* ( , ) ( )rTK BC X T Ke N d
2
0
* ( ) ( )*rT qTK BC X Ke N d qe dT
Plain Binary Option
Random-Expiration Binary Option
Example 1
Suppose that EBV offers the employees of Newco a bonus pool of $5M upon any exit where firm value exceeds $200M. Currently, the firm value of Newco is $40M, and base-case option pricing assumptions (Series A) apply.
Problem What is the current value of this bonus incentive?
Example 2
EBV considering $6M Series A investment in Newco
PCP ($6M APP) for 5M shares, with a QPO threshold at $6 per share.
Pre-money shares = 10M
Question: What is the breakeven valuation?
Example 3
Talltree is considering a $12M Series B investment in Newco
5M shares of PCP, with a QPO at $12 per share. Employee shares = 10M EBV (Series A) has 5M shares of PCPC ($6M APP)
a $6 per share QPO, and a 4X cap.
Questions: 1) What is the exit diagram for the Series A?2) What is the breakeven valuation?
Example 4
XYZ ventures is considering a $20M Series F in Newco for 10M shares of PCP with a QPO threshold of $6 per share.
Employees have claims on 20M shares of common Series A: 10M shares of CP ($6M APP) Series B: 10M shares of CP ($10M APP) Series C: 10M shares of CP ($4M APP and 3X liquidation preference) Series D: 10M shares of PCPC ($10M APP) with 3X cap and $5 QPO Series E: 10M shares of CP ($10M APP) All venture investors have $250M committed capital and $50M in
lifetime fees.Questions1) What is the exit diagram for the Series D PCPC.2) What is the breakeven valuation?